SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
18-Apr-23 11:33 AM View: | BioPharmX Corporation (TMBR) | 15-Apr-23 | Grant | 5,327 | -- | -- | 92% 5.8K to 11.13K | |
16-Dec-22 4:05 PM View: | BioPharmX Corporation (TMBR) | 15-Dec-22 | Grant | 2,500 | $1.63 | $4,072.50 | 76% 3.3K to 5.8K | |
19-Apr-22 12:58 PM View: | BioPharmX Corporation (TMBR) | 15-Apr-22 | Grant | 150,000 | -- | -- | 1000% 15.0K to 165.0K | |
24-Nov-21 4:07 PM View: | BioPharmX Corporation (TMBR) | 23-Nov-21 | Market Purchase | 15,000 | $0.46 | $6,900.00 | 100% 0 to 15.0K | (4%) |
15-Sep-21 8:12 AM View: | 9 Meters Biopharma, Inc. (NMTR) | 14-Sep-21 | Market Purchase | 15,000 | $1.22 | $18,300.00 | 8% 179.34K to 194.34K | (< 1%) |
06-Apr-21 4:15 PM View: | 9 Meters Biopharma, Inc. (NMTR) | 05-Apr-21 | Private Purchase | 50,000 | $1.00 | $50,000.00 | 39% 129.34K to 179.34K | (11%) |
17-Dec-20 4:17 PM View: | 9 Meters Biopharma, Inc. (NMTR) | 15-Dec-20 | Private Purchase | 61,538 | $0.65 | $39,999.70 | 91% 67.8K to 129.34K | |
02-Jul-20 4:26 PM View: | 9 Meters Biopharma, Inc. (NMTR) | 30-Jun-20 | Conversion | 67,800 | -- | -- | 100% 0 to 67.8K | |
16-Nov-16 4:07 PM View: | Vyant Bio, Inc. (VYNT) | 16-Nov-16 | Market Sale | 3,333 | $1.56 | $5,192.81 | (19%) 17.5K to 14.17K | 91% |
16-Nov-15 8:25 AM View: | Vyant Bio, Inc. (VYNT) | 12-Nov-15 | Purchase | 5,000 | -- | -- | 40% 12.5K to 17.5K | |
18-Mar-15 4:03 PM View: | Vyant Bio, Inc. (VYNT) | 16-Mar-15 | Market Purchase | 1,000 | $6.99 | $6,991.90 | 9% 11.5K to 12.5K | (98%) |
15-Dec-14 6:50 PM View: | Vyant Bio, Inc. (VYNT) | 12-Dec-14 | Market Purchase | 500 | $6.26 | $3,130.00 | 5% 11.0K to 11.5K | (98%) |
27-May-14 5:31 PM View: | Vyant Bio, Inc. (VYNT) | 22-May-14 | Grant | 10,000 | -- | -- | 1000% 1.0K to 11.0K | |
22-May-14 4:09 PM View: | Vyant Bio, Inc. (VYNT) | 21-May-14 | Market Purchase | 1,000 | $10.67 | $10,670.00 | 100% 0 to 1.0K | (99%) |